1.57
0.07 (4.67%)
0.07 (4.67%)
Upgrade to Real-Time
Afterhours (Closed)
| Volume | 963,764 |
|
|||||
| News | - | ||||||
| Day High | 1.63 | Low High |
|||||
| Day Low | 1.48 | ||||||
Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| NRX Pharmaceuticals Inc | NRXP | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
 |
|
|---|---|---|---|---|
| 0.07 | 4.67% | 1.57 | 19:57:11 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.53 | 1.48 | 1.63 | 1.49 | 1.50 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 3,809 | 963,764 | $ 1.56 | $ 1,506,432 | - | 1.15 - 26.24 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:58:52 | 1 | $ 1.61 | USD |
Period:
Draw Mode:
NRX Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 104.63M | 66.64M | 36.52M | $ - | $ - | -7.44 | -0.20 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 100.00k | 0.20% |
NRX Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NRXP Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.30 | 1.68 | 1.22 | 1.43 | 762,126 | 0.27 | 20.77% |
| 1 Month | 1.80 | 1.85 | 1.15 | 1.50 | 559,058 | -0.23 | -12.78% |
| 3 Months | 2.80 | 3.54 | 1.15 | 2.36 | 622,177 | -1.23 | -43.93% |
| 6 Months | 5.30 | 10.39 | 1.15 | 5.69 | 1,764,628 | -3.73 | -70.38% |
| 1 Year | 23.01 | 26.24 | 1.15 | 11.73 | 2,691,852 | -21.44 | -93.18% |
| 3 Years | 23.01 | 26.24 | 1.15 | 11.73 | 2,691,852 | -21.44 | -93.18% |
| 5 Years | 23.01 | 26.24 | 1.15 | 11.73 | 2,691,852 | -21.44 | -93.18% |
NRX Pharmaceuticals Description
| NRX Pharmaceuticals Inc is a clinical-stage, small molecule pharmaceutical company which develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. It is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behaviour. |